Hepatocellular Carcinoma in Pakistan: Where do We Stand?

Hepatitis Monthly

Volumn 12, Issue 10, 2012, Pages

  Butt, Amna Subhan ^a   Abbas, Zaigham ^a   Jafri, Wasim ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Carcinoma, Hepatocellular; Hepatitis C; Pakistan

Indexed keywords

EID: 84881183496     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.6023     Document Type: Review

References (53)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-44.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
3. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer. 2007;96(7):1127-34.
4. Ogunbiyi JO. Hepatocellular carcinoma in the developing world. Semin Oncol. 2001;28(2):179-87.
5. Donato F, Boffetta P, MA P. Metaanalysis of epidemiological studies on the combined effect of Hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998;75:347–54.
6. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18 (Suppl 1):S20-2.
7. Jafri W, Subhan A. Hepatitis C in Pakistan: magnitude, genotype, disease characteristics and therapeutic response. Trop Gastroen-terol. 2008;29(4):194-201.
8. Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24(3):346-53.
9. Bhurgri Y, Bhurgri A, Hassan SH, Zaidi SH, Rahim A, Sankaranara-yanan R, et al. Cancer incidence in Karachi, Pakistan: first results from Karachi Cancer Registry. Int J Cancer. 2000;85(3):325-9.
10. Bhurgri Y, Bhurgri A, Pervez S, Bhurgri M, Kayani N, Ahmed R, et al. Cancer profile of Hyderabad, Pakistan 1998-2002. Asian Pac J Cancer Prev. 2005;6(4):474-80.
11. Bhurgri Y. Karachi Cancer Registry Data--implications for the National Cancer Control Program of Pakistan. Asian Pac J Cancer Prev. 2004;5(1):77-82.
12. Bhurgri Y, Pervez S, Kayani N, Bhurgri A, Usman A, Bashir I, et al. Cancer profile of Larkana, Pakistan (2000-2002). Asian Pac J Cancer Prev. 2006;7(4):518-21.
13. Bhurgri Y, Pervez S, Usman A, Khan JA, Bhurgri A, Kasi Q, et al. Cancer patterns in Quetta (1998-1999). J Pak Med Assoc. 2002;52(12):560-5.
14. Jamal S, Moghal S, Mamoon N, Mushtaq S, Luqman M, Anwar M. The pattern of malignant tumours: tumour registry data analysis, AFIP, Rawalpindi, Pakistan (1992-2001). J Pak Med Assoc. 2006;56(8):359-62.
15. Nizami HM, Zuberi SJ. Aflatoxin and liver cancer in Karachi, a pre-liminary survey. J Pak Med Assoc. 1977;27(6):351-2.
16. Iqbal Q, Amjad M, Asi MR, Arino A. Assessment of hot peppers for aflatoxin and mold proliferation during storage. J Food Prot. 2011;74(5):830-5.
17. Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, et al. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan. J Med Virol. 2009;81(7):1189-97.
18. Chohan AR UM, Khar B, Khurram M, Zahid M, Shah SF, et al. De-mographic features of hepatocellular carcinoma: A study of 30 cases. J Rawalpindi Med Coll. 2001;5(2):81-3.
19. Ali R, Iqbal K, Irfan J. Characteristics of Hepatocellular Carcinoma Patients Attending NORI. Ann Pak Inst Med Sci. 2010;6(4):183-5.
20. Abbasi A, Butt N, Bhutto AR, Gulzar K, SM M. Hepatocellular car-cinoma: a clinicopathological study. J Coll Physicians Surg Pak. 2010;20(8):510-3.
21. Butt AK, Khan AA, Alam A, Ahmad S, Shah SW, Shafqat F, et al. Hepatocellular carcinoma: analysis of 76 cases. J Pak Med Assoc. 1998;48(7):197-201.
22. Khokhar N. Multi locular presentation of hepatocellular carci-noma. JPMA. 2001;51(11):407.
23. Ansari S, Memon MS, Devrajani BR. Frequency of hepatitis B and hepatitis C in patients with hepatocellular carcinoma at Hyder-abad. JLUMHS. 2009;8(2):109.
24. Khokhar N, Aijazi I, Gill ML. Spectrum of hepatocellular carcinoma at Shifa International Hospital, Islamabad. J Ayub Med Coll Abbottabad. 2003;15(4):1-4.
25. Idrees M, Rafique S, Rehman I, Akbar H, Yousaf MZ, Butt S, et al. Hepatitis C virus genotype 3a infection and hepatocel-lular carcinoma: Pakistan experience. World J Gastroenterol. 2009;15(40):5080-5.
26. Yusuf MA, Badar F, Meerza F, Khokhar RA, Ali FA, Sarwar S, et al. Survival from hepatocellular carcinoma at a cancer hospital in Pakistan. Asian Pac J Cancer Prev. 2007;8(2):272-4.
27. Butt AS, Hamid S, Ahmad A, Ghufran M, Javed AA, Ahmad B, et al. Hepatocellular carcinoma in Native South Asian Pakistani Popu-lation; Trends, Clinico-pathological characteristics & differences in Viral Marker Negative & Viral-HCC (A 10 year Experience). 9th Asian Pacific Association for the Study of the Liver (APASL) STC on HCC; 2011; Korea.
28. Sharieff S, Burney I, Salam A, Siddiqui T. Hepatocellular Carci-noma. J Coll Physicians Surg Pak. 2002;12(5):264-7.
29. Abbas Z, Qureshi M, Hamid S, Jafri W. Hepatocellular carcinoma in hepatitis D: Does it differ from hepatitis B monoinfection? Saudi J Gastroenterol. 2012;18(1):18-22.
30. Parvez T, Anwar MS. Diagnostic value of Alpha-Fetoprotein in liver cancer. J Coll Physicians Surg Pak. 2001;11(7):431-3.
31. Almani SA, Memon AS, Ghori RA, Memon J, Qureshi AF. Alpha-Fetoprotein as a diagnostic tool in differntiating Hepatocellu-lar Carcinoma from benign hepatic disorders. J Liaquat Uni Med Health. 2004;3(1):7-12.
32. Sharieff S, Burney IA, Salam A, Siddiqui T. Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carci-noma. J Pak Med Assoc. 2001;51(3):123-4.
33. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020-2.
34. Yaqoob J, Bari V, Usman MU, Munir K, Mosharaf F, Akhtar W. The evaluation of hepatocellular carcinoma with biphasic contrast enhanced helical CT scan. J Pak Med Assoc. 2004;54(3):123-7.
35. Abbas Z, Siddiqui AU, Luck NH, Hassan M, Mirza R, Naqvi A, et al. Prognostic factors of survival in patients with non-resectable he-patocellular carcinoma: hepatitis C versus miscellaneous etiol-ogy. J Pak Med Assoc. 2008;58(11):602-7.
36. Gill ML, Atiq M, Sattar S, Khokhar N. Treatment outcomes with long acting octreotide in inoperable hepatocellular carcinoma: a local experience and review of literature. J Pak Med Assoc. 2005;55(4):135-8.
37. Farooqi JI, Farooqi RJ. Efficacy of Octreotide in cases of inoperable hepatocellular carcinoma: A clinical trial. J Coll Phys Surg Pak. 2000;10:258-60.
38. Anis MK, Abbas Z, Jafri W. Oral Capecitabine for the treatment of advanced hepatocellular carcinoma. Pakistan J Gastroenterol. 2011.
39. Shah M, Mori W. Cirrhosis and primary hepatic cancer in Pesha-war, Pakistan. A geographic pathological study. Bull Tokyo Med Dent Univ. 1972;19(2):165-77.
40. Qureshi H, Zuberi SJ, Jafarey NA, Zaidi SH. Hepatocellular carcinoma in Karachi. J Gastroenterol Hepatol. 1990;5(1):1-6.
41. Tong CY, Khan R, Beeching NJ, Tariq WU, Hart CA, Ahmad N, et al. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma. Epide-miol Infect. 1996;117(2):327-32.
42. Abdul Mujeeb S, Jamal Q, Khanani R, Iqbal N, Kaher S. Prevalence of hepatitis B surface antigen and HCV antibodies in he-patocellular carcinoma cases in Karachi, Pakistan. Trop Doct. 1997;27(1):45-6.
43. Kausar S, Shafqat F, Shafi F, Khan AA. The association of hepato-cellular carcinoma with hepatitis B and C viruses. Pak J Gastroen-terol. 1998;12:1-2.
44. Farooqi JI, Farooqi RJ. Relative frequency of hepatitis B and C viruses infections in cases of hepatocellular carcinoma in North West Frontier Province, Pakistan. J Coll Phy Surg Pak. 2000;10:128-30.
45. Farooqi JI, Farooqi RJ. Prevalence of Hepatocellular Carcinoma in Patients of Liver Cirrhosis: An Experience in North West Frontier Province (NWFP). J Coll Physicians Surg Pak. 2000;10(2):54-5.
46. Sharieff S, Burney KA, Ahmad N, Salam A, Siddiqui T. Radiological features of hepatocellular carcinoma in Southern Pakistan. Trop Doct. 2001;31(4):224-5.
47. Mumtaz MS, Iqbal R, Umar M, Khar B, Mumtaz MO, Anwar F, et al. Sero-prevalence of hepatitis B and C viruses in hepatocellular carcinoma. J Rawal Med Coll. 2001;5(2):78-80.
48. Khokhar N. Spectrum of chronic liver disease in a tertiary care hospital. J Pak Med Assoc. 2002;52(2):56-8.
49. Hamza N. Proc World Congress of Epidemiology 2005; Bangkok, Thailand.
50. Zia ud Din, Muhammad R, Saeedi MI, Mahmood K. Frequency of hepatoma in hepatitis B and C positive cirrhotic patients. J Post-grad Med Inst. 2006;20(4):325-29.
51. Baig JA, Alam JM, Mahmood SR, Baig M, Shaheen R, Sultana I, et al. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP). J Ayub Med Coll Abbottabad. 2009;21(1):72-5.
52. Nawaz A, Chaudhry A, Riaz M, Yousaf M, Alvi A, Batool S, et al. Presentation of Hepatocellular Cancer in the Developing World: An Analysis of the Presentation and Association with Chronic Hepatitis B and C. AJG. 2011;106(supplement 2):S126.
53. Shah GG, Qureshi IA, Hakim T, Tarin BA, Farooq MA, Qureshi PS. Radiological aspects of hepatocellular carcinoma: A hospital based study. Pak Armed Forces Med Jour. 1999;49:54.